Stock listing

Assembly Biosciences, Inc.

Selected listing: ASMB · NASDAQ · USD · US

Assembly Biosciences, Inc. (NASDAQ:ASMB), Health Technology. Latest release Oct 5, 2026: Assembly Biosciences to Present Positive Phase 1a Safety…

ASMB:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:ASMB
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: NASDAQ
Currency: USD

About Assembly Biosciences, Inc.

Assembly Biosciences, Inc. is a public company traded under the ticker ASMB in the American market. Assembly Biosciences focuses on developing innovative therapies for viral infections, particularly hepatitis B.

Latest news from Assembly Biosciences, Inc.

Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026

October 5, 2026

Assembly Biosciences to Present Positive Phase 1a Safety, Tolerability and Target Engagement Data for ABI-6250 at AASLD The Liver Meeting® 2026

October 4, 2026

Assembly Biosciences to Present at the H.C. Wainwright & Co. 28th Annual Global Investment Conference

September 10, 2026

Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program

September 8, 2026

Assembly Biosciences Reports Second Quarter 2026 Financial Results and Recent Updates

August 13, 2026

All Assembly Biosciences, Inc. news →

Events

Replays

Assembly Biosciences, Inc. (ASMB) Q3 2020 Earnings Call
Thu, Nov 05, 2020 · 05:00 PM ET
Watch

Research Assembly Biosciences, Inc.

Assembly Biosciences, Inc. company profile

View the public company page for Assembly Biosciences, Inc. on 6ix.

Assembly Biosciences, Inc. news

Read company news and market updates connected to Assembly Biosciences, Inc..

Assembly Biosciences, Inc. investor events

Find investor webinars, events, and replay context for Assembly Biosciences, Inc..